BioLineRX Ltd. : BioLineRx Announces Regulatory Submission for Novel Stem … – 4-traders (press release)
|
BioLineRX Ltd. : BioLineRx Announces Regulatory Submission for Novel Stem …
4-traders (press release) Secondary objectives include assessment of the efficacy of BL-8040 in mobilizing stem cells as a stand-alone therapy, as well as monitoring the pharmacokinetic profile of the drug. This part will be performed in up to 4 cohorts, with 8 healthy … |
